SynapDx gets $6M boost to conduct autism test study

12/12/2012 | MedCityNews.com

SynapDx has obtained $6 million in financing, which it aims to use to support pivotal trials of a blood assay for diagnosing autism spectrum disorders in children as young as 36 months. The company plans to launch a study next year to evaluate the use of the test in validating performance attributes in 600 children who are at risk for ASD.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC